You are here
- Home
- Therapy Areas
- Gastrointestinal
Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in France (REMAIN)
- Disease
- gastroesophageal reflux disease
- Drug Name
- AZD3355
- Generic Name
- AZD3355
- Sponsor
- AstraZeneca
- Drug Status
- Discontinued
- Phase
- Non-Interventional Study
- Start Date
- Feb 5, 2009
- Study Name
- D9120N00013
- Study Id
- D9120N00013
- ClinicalTrials.gov ID
- NCT00842855
- Recruiting Status
- Closed
- Protocol
-
Nov 5, 2008
- D9120N00013.pdf (375 KB)
- Report
-
May 27, 2011
- D9120N00013.pdf (696 KB)
